Comparison
Lion's Mane vs Tirzepatide
Side-by-side of Lion's Mane and Tirzepatide. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Lion's Mane
Lion's mane mushroom (Hericium erinaceus) supplement profile: hericenones and erinacines stimulate NGF in vitro. Human cognition trials are small.
Tirzepatide
Tirzepatide for weight loss: dual GIP/GLP-1 agonist sold as Mounjaro and Zepbound. SURMOUNT-1 showed 22.5% mean body-weight loss at 15 mg over 72 weeks.
Effects at a glance
Lion's Mane
- •Edible medicinal mushroom containing NGF-stimulating hericenones and erinacines
- •Mori 2009 trial (n=30) in mild cognitive impairment showed cognitive improvement at 3 g/day for 16 weeks, reversing 4 weeks after discontinuation
- •Saitsu 2019 (n=31) in older adults reported MoCA improvements at 3.2 g/day over 12 weeks
- •Multiple small mood trials suggest reduced anxiety and depression scores at 1 to 4 g/day extract
- •Mechanistic case rests on NGF stimulation and remyelination support; in vivo human NGF measurement is absent
- •Product quality varies substantially; mycelium-on-grain products can be over 50% grain by weight
Tirzepatide
- •Dual GIP plus GLP-1 receptor agonist with a ~5-day half-life supporting once-weekly subcutaneous dosing
- •SURMOUNT-1 reported ~22.5% mean body-weight loss at 15 mg over 72 weeks versus 2.4% on placebo
- •Lowers HbA1c by ~1.9 to 2.6 percentage points in type 2 diabetes across SURPASS trials
- •Outperformed semaglutide 1.0 mg head-to-head on weight loss and HbA1c in SURPASS-2
- •GI effects (nausea, diarrhea, vomiting) drive most discontinuations and ease with slow titration
- •Lean-mass loss observed in body-composition substudies; resistance training and protein intake mitigate this
Side-by-side
| Attribute | Lion's Mane | Tirzepatide |
|---|---|---|
| Category | natural | pharmaceutical |
| Also known as | Hericium erinaceus, Yamabushitake, Bearded Tooth, Hou Tou Gu | Mounjaro, Zepbound, LY3298176 |
| Half-life (hr) ↗ | 6 | 120 |
| Typical dose (mg) ↗ | 1000 | 10 |
| Dosing frequency | 1 to 2 times daily | weekly |
| Routes | oral | subcutaneous |
| Onset (hr) | 168 | 24 |
| Peak (hr) | 1344 | 72 |
| Molecular weight | - | 4813.45 |
| Molecular formula | mixed extract | C225H348N48O68 |
| Mechanism | Hericenones and erinacines stimulate NGF mRNA expression and NGF protein release in cultured neurons; secondary anti-inflammatory and remyelination-supportive activity in preclinical models. | Synthetic 39-amino-acid peptide that activates both GIP and GLP-1 receptors. Potentiates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic and brainstem satiety circuits. |
| Legal status | Dietary supplement and food worldwide; unscheduled and unrestricted | Prescription only; FDA-approved 2022 (T2DM, Mounjaro) and 2023 (chronic weight management, Zepbound) |
| WADA status | allowed | allowed |
| DEA / Rx | OTC supplement and food | Rx only (not a controlled substance) |
| Pregnancy | Insufficient data for routine supplementation; consumed historically as food without documented harm | Not recommended; discontinue 2 months before planned pregnancy |
| CAS | 2023788-19-2 | |
| PubChem CID | 156588324 | |
| Wikidata | Q146050 | Q105099794 |
Safety profile
Lion's Mane
Common side effects
- mild GI upset
- occasional skin rash
- contact dermatitis (rare)
Contraindications
- mushroom allergy
Interactions
- anticoagulants: theoretical antiplatelet effect, no documented clinical events(minor)
Tirzepatide
Common side effects
- nausea
- diarrhea
- vomiting
- constipation
- decreased appetite
- injection-site reactions
- fatigue
- abdominal pain
Contraindications
- personal or family history of medullary thyroid carcinoma
- multiple endocrine neoplasia type 2
- pregnancy
- history of pancreatitis (use caution)
- severe gastroparesis
Interactions
- insulin: additive hypoglycemia risk; insulin dose typically reduced(major)
- sulfonylureas (glipizide, glyburide): hypoglycemia risk, sulfonylurea dose often reduced(major)
- oral medications (general): delayed gastric emptying can alter absorption kinetics(moderate)
- oral contraceptives: reduced exposure after first dose; backup contraception recommended for 4 weeks after initiation and each dose escalation(moderate)
- warfarin: monitor INR due to altered absorption(moderate)
Which Should You Take?
Lion's Mane comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. Tirzepatide is the right call when one of the conditionals below applies.
- → If your priority is focus or working memory, pick Lion's Mane.
- → If your priority is nerve health, pick Lion's Mane.
- → If your priority is metabolic health and glucose control, pick Tirzepatide.
- → If your priority is fat loss, pick Tirzepatide.
Edge case: If you want to avoid prescription-only, Lion's Mane is the more accessible choice.
Default choice: Lion's Mane. Lower friction to source, and broader goal coverage. Reach for Tirzepatide only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Lion's Mane and Tirzepatide?
Lion's Mane and Tirzepatide differ in category (natural vs pharmaceutical), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Lion's Mane or Tirzepatide?
Lion's Mane half-life is 6 hours; Tirzepatide half-life is 120 hours.
Can you stack Lion's Mane with Tirzepatide?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper